semaglutide and anavar nejm Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential Semaglutide prevents cardiovascular events regardless

While some epidemiological studies have raised questions about growth hormone and cancer risk, the evidence remains inconclusive after decades of clinical use

How to overcome your lack of appetite on GLP-1s Hunger suppression means the medication is doing its job, but it can make mealtimes uncomfortable

In this blog, youll learn about allulose, its track record as a low-calorie sweetener, and how it compares with xylitol, monk fruit, and stevia

Heavy fatigue or a large heart-rate response indicates that the bridge has not settled

Ipamorelin is a selective GHRP that stimulates pituitary GH release

Archana Sadhu, an endocrinologist and head of the diabetes program at Houston Methodist